G75A (p.Gly75Ala) variant of KRT4 (Keratin, type II cytoskeletal 4)

G75A (p.Gly75Ala) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes population frequency data and structural context.

G75A (p.Gly75Ala) variant details